Hyperglycemia found at any stage during pregnancy should be classed as diabetes mellitus in pregnancy or gestational diabetes mellitus, according to the World Health Organization. Women with diabetes and women with intermediate hyperglycemia, impaired glucose tolerance (IGT), and impaired fasting glycemia (IFG) as described in non-pregnant individuals are included in current definitions of gestational diabetes. The use of insulin in gestational diabetes mellitus is recommended at a category B level, whereas the use of an oral hypoglycemic medication is recommended at a category C level. The risk of hypoglycemia in both the mother and the foetus is the same regardless of whether glucose lowering drug is taken, whether injectable or oral. This feature is what makes the Ademolus Classification of Hypoglycaemia (ACH) a useful tool in evaluating hypoglycemia complicating the management of gestational diabetes mellitus. It’s worth noting that outcomes from research on maternal hypoglycemia varied, owing in part to discrepancies in hypoglycemia definitions. This is one of the knowledge gaps and disputes that Ademolus Classification of Hypoglycemia in Gestational Diabetes Mellitus Management Complication will help to address. It will assist to unify the concept of hypoglycemia regardless of race and allow for objective data comparison. ACH will make continuous glucose monitoring interpretation easier. The more we use ACH, the more we will notice gaps in our existing knowledge, gain insight into hypoglycemia complicating gestational diabetes mellitus, and become more scientifically knowledgeable, as it will open up a new path of scientific understanding of fetomaternal pathophysiology for the benefit of mankind.



Author (s) Details

Dr. Adegbenga B. Ademolu
Medicine Department, Lagos State University Teaching Hospital, Lagos, Nigeria.

View Book :- https://stm.bookpi.org/HMMS-V11/article/view/2498